MRFF 2020 Quality, Safety and Effectiveness of Medicine Use and Medicine Intervention by Pharmacists Grant Opportunity

This grant provides researchers with funding to improve the safe and effective use of medicines
This grant is currently closed to applications

What do you get?

Up to $2.5 million to support medical research and medical innovation projects.

Who is this for?

Eligible organisations seeking to improve medical innovation.


The 2020 Quality, Safety and Effectiveness of Medicine Use and Medicine Intervention by Pharmacists grant opportunity is part of the Medical Research Future Fund (MRFF) and the Preventive and Public Health Research Initiative.

It will support research to

  • test innovative public health approaches
  • identify innovative approaches to treat and manage chronic and complex diseases
  • improve the quality and cost-effectiveness of preventive healthcare interventions

It will provide grants to support medical research and innovation projects that create or adapt:

  • technologies
  • mechanisms
  • approaches

Projects should aim to improve medicine use and medicine intervention by pharmacists in primary health and transitions of care. They should target improvements to quality, safety and effectiveness. The projects should also align with relevant peak or representative bodies to help national implementation.

Intended outcomes

The intended outcome of the research funded by this grant opportunity is to improve the health and wellbeing of Australians.

It will promote the safe and effective use of medicines, particularly in high-risk groups and settings such as:

  • the elderly
  • people with complex chronic diseases
  • rural and remote communities
  • Aboriginal and Torres Strait Islander peoples
  • culturally and linguistically diverse people and communities
  • aged care facilities

It also aims to reduce adverse drug events and medicine-related hospital admissions.


What are the eligibility criteria?

To be eligible you must:

  • have an Australian business number (ABN)
  • be incorporated in Australia

You must also be one of the following entities:

  • a medical research institute
  • a university
  • a corporate Commonwealth entity
  • a corporation (including businesses and not for profits)
  • a state or territory government
  • a state or territory government entity

We encourage joint applications provided you have a lead organisation who is the main driver of the project and is eligible to apply.

We can only accept applications where you can provide:

  • details of your nominated Chief Investigator A (CIA), the person who will take the lead role in conducting the project
  • details of all members of your research team are listed as Chief Investigators (CIs)
  • evidence from your board (or chief executive officer or equivalent if there is no board) that the project is supported, and that you can complete the project and meet the costs of the project not covered by grant funding
  • letters of support from each project partner, where applicable

You are not eligible to apply if you are:

  • an individual
  • partnership
  • unincorporated association
  • any organisation not included in section 3.1 of the guidelines
  • trust (however, an incorporated trustee may apply on behalf of a trust)
  • a non-corporate Commonwealth entity.


How do you apply?

The MRFF 2020 Quality, Safety and Effectiveness of Medicine Use and Medicine Intervention by Pharmacists Grant Opportunity is closed to applications.

We assess your application against the eligibility criteria. Then, an independent committee of experts will assess eligible applications against the assessment criteria. Only eligible applications will proceed to the assessment stage.

You should provide detail and supporting evidence that is relative to the project. You should consider the project size, complexity and grant amount requested. The sample application form displays character limits.

The program delegate will make the final decision. They'll take into consideration the recommendations from the independent committee of experts.

We will assess your application based on the weighting given to each criteria.

  • Assessment criterion 1: Project impact (40% weighting)
  • Assessment criterion 2: Project methodology (30% weighting)
  • Assessment criterion 3: Capacity, capability and resources to deliver the project capacity, capability and resources to deliver the project (30% weighting)
  • Assessment criterion 4: Overall Value and Risk of the Project (non-weighted)

If your application is successful, you’ll receive a written offer. If you’re unsuccessful, we’ll notify you in writing and give you the chance to discuss the outcome with us.

Successful applicants must enter into a grant agreement with the Commonwealth.

The grant agreement will specify the:

  • reporting requirements
  • payment schedule
  • milestones necessary to receive payments

We’ll make payments according to an agreed schedule set out in the grant agreement. Payments are subject to satisfactory progress on the project.

We’ll make payments by direct credit into a nominated bank account.

Need help?

Let us answer your question via phone, email or live chat. And if we can't help, we'll put you in touch with someone who can.

  • Phone:
  • Open Hours:
    Monday – Friday, 8am – 8pm across Australia
  • Website:

Key documents

Sample application form

pdf · 0.57 MB docx · 0.18 MB

Sample grant agreement

pdf · 0.61 MB docx · 0.10 MB

Independent audit report template

pdf · 0.35 MB docx · 0.05 MB

MRFF grant management resources

Reporting templates are available from the MRFF grants management webpage. The page also provides other resources for MRFF grant administration, including current policies and relevant forms and templates.

Was this page helpful?